Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
224.8 USD | -3.36% | -2.32% | -4.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.93% | 1.16TCr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.17% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Guggenheim Adjusts Price Target on Charles River Laboratories International to $225 From $255, Maintains Buy Rating